Aquigen Bio Sciences

  Abemaciclib D7 , a high-purity deuterated reference standard offered by  AquigenBio , is transforming the landscape of pharmaceutical analysis and research. As drug development protocols and quality regulations become increasingly stringent, laboratories and pharmaceutical companies require advanced reference materials that deliver both reliability and compliance. Abemaciclib D7 meets these critical needs, empowering scientists with a tool that drives accuracy in method development, validation, and quality control. What Is Abemaciclib D7? Abemaciclib D7 is a stable isotope-labeled analog of abemaciclib, a potent cyclin-dependent kinase (CDK) 4/6 inhibitor commonly used in the treatment of specific breast cancer subtypes. By incorporating deuterium (D7) atoms, this reference standard allows for highly specific and sensitive analytical applications — particularly in pharmacokinetics, bioanalysis, and impurity profiling. Key Chemical Details Molecular Formula:  C27H25D7F2N...

  Resmetirom is a breakthrough thyroid hormone receptor-β agonist, currently under investigation for the treatment of nonalcoholic steatohepatitis (NASH). The successful development, validation, and filing of Resmetirom-based therapies require precision in impurity profiling—a critical cornerstone of global regulatory acceptance. Why Choose AquigenBio’s Resmetirom Impurities? High-Purity Reference Standards :  Each impurity is synthesized and purified to >95% purity, with robust documentation including HPLC, MS, and NMR characterization data for your quality assurance. Regulatory Readiness : All products are crafted to support compliance with FDA, EMA, and ICH guidelines. They are essential for AMV, ANDA, DMF, and NDA submissions, helping you meet impurity identification thresholds and avoid regulatory bottlenecks. Quick Turnaround & Reliable Supply : AquigenBio’s impurities are available for immediate dispatch, mi...